DirectorAstraZenecaGaithersburg, Maryland, United States
Advances and Challenges in Oligonucleotide and mRNA Therapeutics: New Strategies and Regulatory Perspectives (S12)
Tuesday, November 19, 20242:00 PM - 5:00 PM CT
Nonclinical Safety Assessments of the Next Generation of mRNA Vaccines for SARS-CoV-2 and Other Respiratory Viruses (S12-3)
Tuesday, November 19, 20242:40 PM - 3:15 PM CT